M P Simunovic1, B C Regan, J D Mollon. 1. Department of Experimental Psychology, Cambridge University, Cambridge, United Kingdom. m.p.simunovic@apu.ac.uk
Abstract
PURPOSE: To examine experimentally whether color vision deficiency confers a selective advantage under scotopic conditions. METHODS: Red-green color-deficient subjects, monochromats, and age-matched color-normal control subjects were examined. In each subject the time course of dark adaptation, scotopic visual field sensitivity, and performance on a scotopic perceptual task were measured. RESULTS: No significant differences were found between red-green color-deficient subjects and control subjects on any of the three tests. Our small sample of monochromats had higher absolute thresholds than the corresponding control subjects, but their performance at the scotopic visual field test and perceptual task did not differ significantly from that of color-normal subjects. CONCLUSIONS: No evidence was found that red-green color deficiency or monochromatism confers a selective advantage under scotopic conditions.
PURPOSE: To examine experimentally whether color vision deficiency confers a selective advantage under scotopic conditions. METHODS: Red-green color-deficient subjects, monochromats, and age-matched color-normal control subjects were examined. In each subject the time course of dark adaptation, scotopic visual field sensitivity, and performance on a scotopic perceptual task were measured. RESULTS: No significant differences were found between red-green color-deficient subjects and control subjects on any of the three tests. Our small sample of monochromats had higher absolute thresholds than the corresponding control subjects, but their performance at the scotopic visual field test and perceptual task did not differ significantly from that of color-normal subjects. CONCLUSIONS: No evidence was found that red-green color deficiency or monochromatism confers a selective advantage under scotopic conditions.
Authors: Jonathan Aboshiha; Vy Luong; Jill Cowing; Adam M Dubis; James W Bainbridge; Robin R Ali; Andrew R Webster; Anthony T Moore; Frederick W Fitzke; Michel Michaelides Journal: Invest Ophthalmol Vis Sci Date: 2014-08-28 Impact factor: 4.799
Authors: Jonathan Aboshiha; Adam M Dubis; Joseph Carroll; Alison J Hardcastle; Michel Michaelides Journal: Br J Ophthalmol Date: 2015-03-13 Impact factor: 4.638
Authors: Ravid Doron; Anna Sterkin; Moshe Fried; Oren Yehezkel; Maria Lev; Michael Belkin; Mordechai Rosner; Arieh S Solomon; Yossi Mandel; Uri Polat Journal: PLoS One Date: 2019-01-23 Impact factor: 3.240